Aqemia

French tech company | Builders Republic

About

Drug-discovery company combining quantum-inspired physics simulations with generative AI to design novel drug candidates for pharma partners — generating its own in-house data to predict how molecules bind and behave, applied to oncology and central-nervous-system targets.

Key facts

Status
Active
Sectors
Healthcare & Life Sciences
Latest stage
Series C
Founded
2019
City
PARIS
Region
IDF
Legal name
AQEMIA
SIREN
851519702
Tracked rounds
4
Amount raised
97 M€ raised since 2020

Recognition

  • French Tech Next40

Funding rounds

  • Series C — 2024
  • Series B — 2024
  • Series A — 2022
  • Pre-seed — 2019

Investors